ADA Scientific Sessions 2025 Abstract

Cardiovascular Efficacy of Evolocumab in Persons with Type 1 Diabetes Mellitus—Insights from FOURIER Trial

By Yu Mi Kang, Robert Patrick Giugliano, Xinhui Ran, Lawrence A. Leiter

Trial in peopleInterventions

The paper

Yu Mi Kang, Robert Patrick Giugliano, Xinhui Ran, Lawrence A. Leiter

University of Oxford

ADA Scientific Sessions 2025 Abstract, 20 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 1991-LB

doi.org/10.2337/db25-1991-lb

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety